These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 16413004)
1. The importance of estimating the therapeutic index in the development of matrix metalloproteinase inhibitors. Peterson JT Cardiovasc Res; 2006 Feb; 69(3):677-87. PubMed ID: 16413004 [TBL] [Abstract][Full Text] [Related]
2. MMP inhibitors in cardiac diseases: an update. Dormán G; Kocsis-Szommer K; Spadoni C; Ferdinandy P Recent Pat Cardiovasc Drug Discov; 2007 Nov; 2(3):186-94. PubMed ID: 18221118 [TBL] [Abstract][Full Text] [Related]
3. Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial. Hudson MP; Armstrong PW; Ruzyllo W; Brum J; Cusmano L; Krzeski P; Lyon R; Quinones M; Theroux P; Sydlowski D; Kim HE; Garcia MJ; Jaber WA; Weaver WD J Am Coll Cardiol; 2006 Jul; 48(1):15-20. PubMed ID: 16814643 [TBL] [Abstract][Full Text] [Related]
4. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models. Baragi VM; Becher G; Bendele AM; Biesinger R; Bluhm H; Boer J; Deng H; Dodd R; Essers M; Feuerstein T; Gallagher BM; Gege C; Hochgürtel M; Hofmann M; Jaworski A; Jin L; Kiely A; Korniski B; Kroth H; Nix D; Nolte B; Piecha D; Powers TS; Richter F; Schneider M; Steeneck C; Sucholeiki I; Taveras A; Timmermann A; Van Veldhuizen J; Weik J; Wu X; Xia B Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489 [TBL] [Abstract][Full Text] [Related]
5. Insight into the structural determinants for selective inhibition of matrix metalloproteinases. Pirard B Drug Discov Today; 2007 Aug; 12(15-16):640-6. PubMed ID: 17706545 [TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase inhibitor development and the remodeling of drug discovery. Peterson JT Heart Fail Rev; 2004 Jan; 9(1):63-79. PubMed ID: 14739769 [TBL] [Abstract][Full Text] [Related]
7. Can matrix metalloproteinase inhibitors provide a realistic therapy in cardiovascular medicine? MacFadyen RJ Curr Opin Pharmacol; 2007 Apr; 7(2):171-8. PubMed ID: 17317319 [TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of an orally active matrix metalloproteinase inhibitor. Yamamoto S; Nakatani S; Ikura M; Sugiura T; Nishita Y; Itadani S; Ogawa K; Ohno H; Takahashi K; Nakai H; Toda M Bioorg Med Chem; 2006 Sep; 14(18):6383-403. PubMed ID: 16765051 [TBL] [Abstract][Full Text] [Related]
11. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure]. Yang YJ; Zhang X; Zhu WL; Huang Y Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324 [TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176 [TBL] [Abstract][Full Text] [Related]
13. [Design, synthesis and activity evaluation of novel matrix metalloproteinases inhibitors based on the structure of enzyme]. Jia H; Guo YS; Ge YY; Wen H; Yang J; Yang XY; Du GH; Yang GZ Yao Xue Xue Bao; 2007 Dec; 42(12):1271-81. PubMed ID: 18338640 [TBL] [Abstract][Full Text] [Related]
14. A new development of matrix metalloproteinase inhibitors: twin hydroxamic acids as potent inhibitors of MMPs. Rossello A; Nuti E; Catalani MP; Carelli P; Orlandini E; Rapposelli S; Tuccinardi T; Atkinson SJ; Murphy G; Balsamo A Bioorg Med Chem Lett; 2005 May; 15(9):2311-4. PubMed ID: 15837315 [TBL] [Abstract][Full Text] [Related]
15. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Spinale FG Physiol Rev; 2007 Oct; 87(4):1285-342. PubMed ID: 17928585 [TBL] [Abstract][Full Text] [Related]
16. Recent advances in MMP inhibitor design. Fisher JF; Mobashery S Cancer Metastasis Rev; 2006 Mar; 25(1):115-36. PubMed ID: 16680577 [TBL] [Abstract][Full Text] [Related]
17. [Tumor metastasis and MMP inhibitor]. Sato H Clin Calcium; 2006 Apr; 16(4):621- 26. PubMed ID: 16582513 [TBL] [Abstract][Full Text] [Related]